Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Cellectis S.A. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +2 vs. Q3 2024
- Shares held
- 12.8M
- +2.99M (+30.6%) vs. Q3 2024
- Total value
- $23.0M
- +$2.10M (+10.1%) vs. Q3 2024
- New holders
- 6
- 6 more added
- Sold out
- 4
- 6 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EverSource Wealth Advisors, LLC | 13 | $23 | 0.00% | 00.0% | Unchanged |
| Principal Securities, Inc. | 52 | $94 | 0.00% | +52 | New |
| Bank of America Corp | 77 | $139 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 303 | $546 | 0.00% | +303 | New |
| Allworth Financial LP | 500 | $765 | 0.00% | 00.0% | Unchanged |
| POM Investment Strategies, LLC | 495 | $891 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 2,115 | $3.81K | 0.00% | −1,740−45.1% | Reduced |
| National Bank of Canada | 3,600 | $6.48K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 4,500 | $8.10K | 0.00% | −1,600−26.2% | Reduced |
| JPMorgan Chase & Co | 5,573 | $10.0K | 0.00% | +5,490+6,614.5% | Added |
| XTX Topco Ltd | 10,526 | $18.9K | 0.00% | −2,569−19.6% | Reduced |
| Geode Capital Management, LLC | 10,776 | $19.4K | 0.00% | 00.0% | Unchanged |
| Baird Financial Group, Inc. | 15,090 | $27.2K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 19,916 | $34.0K | 0.00% | +19,916 | New |
| BNP Paribas Arbitrage, SA | 22,400 | $40.3K | 0.00% | +4,000+21.7% | Added |
| Wells Fargo & Company | 24,590 | $44.3K | 0.00% | +12,500+103.4% | Added |
| First Affirmative Financial Network | 25,863 | $46.6K | 0.03% | +4,769+22.6% | Added |
| Two Sigma Investments, LP | 27,322 | $49.2K | 0.00% | −6,090−18.2% | Reduced |
| Citadel Advisors LLC | 34,786 | $62.6K | 0.00% | +7,162+25.9% | Added |
| LPL Financial LLC | 85,272 | $153.5K | 0.00% | −7,100−7.7% | Reduced |
| Morgan Stanley | 198,694 | $357.7K | 0.00% | +107,169+117.1% | Added |
| Macquarie Group Ltd | 226,875 | $408.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 229,081 | $412.3K | 0.00% | +229,081 | New |
| Baillie Gifford & Co | 290,429 | $522.8K | 0.00% | −403,510−58.1% | Reduced |
| Millennium Management LLC | 534,551 | $962.2K | 0.00% | +534,551 | New |
| UBS Asset Management Americas Inc | 1,438,255 | $2.59M | 0.00% | 00.0% | Unchanged |
| Capital International Investors | 1,848,804 | $3.33M | 0.00% | 00.0% | Unchanged |
| B Group, Inc. | 3,081,501 | $5.55M | 3.39% | +3,081,501 | New |
| Long Focus Capital Management, LLC | 4,617,293 | $8.31M | 0.64% | 00.0% | Unchanged |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −411,800−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −163,447−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,010−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −2,755−100.0% | Sold out |